Insider · CIK 0001339484
Eric E Poma
Files at CLDI (Calidi Biotherapeutics, Inc.). First filing Aug 25, 2025, latest Aug 25, 2025.
In brief
Eric E Poma files SEC Form 4 as CEO and director at CLDI (Calidi Biotherapeutics, Inc.). Since Aug 25, 2025, Eric E Poma has reported 1 open-market buy worth $50k and 0 open-market sells worth $0, the latest filed on Aug 25, 2025.
A track record needs three past buys with six months of prices behind them; Eric E Poma has 0, so none is measured yet.
The newest scored trade: bought $50k of CLDI on Aug 21, 2025, filed Aug 25, 2025, scored 73 (notable).
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
CLDI: Calidi Biotherapeutics, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 73Notable | Calidi Biotherapeutics, Inc. | $50k 25,000 shares | - | 0% from low-96% from high |
Transactions
Every row this insider has filed, 5 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Aug 17, 2026 | CLDI Calidi Biotherapeutics, Inc. | AGrant or award Stock Options (right to buy)derivative | +32,000 | - | - | 32,000 | Aug 19, 2026 |
| Sep 3, 2025 | CLDI Calidi Biotherapeutics, Inc. | AGrant or award Stock Options (right to buy)derivative | +10,000 | - | - | 10,000 | Sep 5, 2025 |
| Aug 21, 2025 | CLDI Calidi Biotherapeutics, Inc. | POpen-market purchase Common Stock | +25,000 | $2.00 | $50k | 25,000 | Aug 25, 2025 |
| Aug 21, 2025 | CLDI Calidi Biotherapeutics, Inc. | POpen-market purchase Warrant (right to buy)derivative | +25,000 | - | - | 25,000 | Aug 25, 2025 |
| Apr 22, 2025 | CLDI Calidi Biotherapeutics, Inc. | AGrant or award Stock Option (right to buy)derivative | +726,412 | - | - | 726,412 | Apr 25, 2025 |
Questions about Eric E Poma
Answered from the filings on this page, as of the latest one.
Is Eric E Poma buying or selling?
Not in the last 12 months. Eric E Poma's latest open-market trade on SEC Form 4 was bought $50k of CLDI on Aug 21, 2025.
How did Eric E Poma's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Eric E Poma has 0.
Where does Eric E Poma file Form 4?
Eric E Poma has filed Form 4 at CLDI (Calidi Biotherapeutics, Inc.) as Chief Executive Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.